INTRODUCTION
Desmoid tumors are rare tumors and are characterized by aggressive fibroblastic proliferation (1) . The risk of developing a desmoid tumor increases more than 800-fold in patients with familial adenomatous polyposis including Gardner syndrome (1) .
Desmoid tumors are non-malignant and do not metastasize, but they can be fatal through local invasion (1) . This tumor has infiltrative features and can result in urinary tract obstruction, and occasionally, an abscess or fistula (1) . However, ureteral fistulas caused by desmoid tumors are rarely reported (2) (3) (4) .
Renal scintigraphy using Tc-99m diethylenetriamine pentaacetic acid (DTPA) has been widely used to evaluate renal function and true obstructive uropathy. Furthermore, some studies have reported the utility of renal DTPA scintigraphy for detecting abnormal formation of the urinary tract (3, 5) .
We report a case of a patient with Gardner syndrome, in whom renal scintigraphy with Tc-99m DTPA revealed bilateral ureterotumoral fistulas caused by an intra-abdominal desmoid tumor, which changed the treatment plan.
CASE REPORT
A 35-year-old woman with Gardner syndrome presented to our medical center with abrupt onset abdominal pain. She had undergone total colectomy at the age of 29 years, and a mass lesion in the small bowel mesentery detected 1 year previously was histologically confirmed to be a desmoid tumor ( Fig. 1 Desmoid tumors are rare benign tumors with aggressive fibroblastic proliferation. Although desmoid tumors do not metastasize, they have locally aggressive features and can cause a urinary fistula. Here, we report a case of a 35-year-old woman with Gardner syndrome who was diagnosed with an intra-abdominal desmoid tumor 1 year previously and who presented with a newly developed cystic mass lesion on a computed tomography scan. The cystic mass lesion was clinically diagnosed as an urinoma from the right ureterotumoral fistula; thus, surgical resection of the mass lesion was planned. However, Tc-99m diethylenetriamine pentaacetic acid renal scintigraphy revealed bilateral ureterotumoral fistulas; hence, the treatment plan was changed to conservative management. The patient' s vital signs were stable on admission. Laboratory results revealed the upper normal limit of the white blood cell (WBC) count (10.2 × 10 3 /μL; normal range, 4.0-10.8 × 10 3 /μL), a low hemoglobin level (9.7 g/dL; normal range, 12.0-16.0 g/dL), a low platelet count (100.0 × 10 3 /μL; normal range, 130-400 × 10 3 / μL), a normal creatinine level (1.2 mg/dL; normal range, 0.5-1.2 mg/dL), and a high C-reactive protein level (69.8 mg/dL). The results of a WBC differential test revealed a high differential neutrophil count of 92.2%.
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Contrast-enhanced abdominal computed tomography (CT)
was performed to evaluate the abdominal pain, which revealed the already identified desmoid tumor in the small bowel mesentery but no significant interval change in its size compared to that on the previous CT scan. However, a new 5 cm in size poorly-enhanced infiltrative mass lesion containing fluid and a small air density was detected at the mesenteric root ( Fig. 1 ). An abscess combined with the desmoid tumor was suspected. Percutaneous drainage (PCD) of the new cystic mass lesion was performed.
After PCD and antibiotic treatment, the cystic mass lesion shrank, but it continued to drain. The color of the leaking fluid was clear and yellowish, suggesting urine. No definite connection was observed between the ureter and the new mass lesion on CT, but a right ureterotumoral fistula was suspected based on the location of the mass. We suspected a right ureterotumoral fistula and an urinoma from urine leakage based on the CT findings and planned to surgically resect the mass and urinoma and repair the right ureter.
Tc-99m DTPA renal scintigraphy was performed preopera-tively to assess the ureterotumoral fistula. Cut-off of the radioactivity was observed at bilateral mid-ureters during the excretion phase on dynamic renal scintigraphy images, suggesting bilateral ureterotumoral fistulas (Fig. 2) . No radioactivity was observed in the cystic mass lesion because of PCD. On the other hand, radioactivity was found in the urine contained in the PCD tubes and the PCN tubes and urinary bladder, confirming the presence of an ureterotumoral fistula. F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT was also performed to detect a hidden malignancy other than the desmoid tumor (Fig. 3) .
The PCD tube was locked just before the PET/CT scan and urine activity was seen instantly inside the cystic mass lesion. No abnormal increase in FDG uptake was detected to suggest a hidden malignancy, and the desmoid tumor lesion only showed a mildly increased FDG uptake.
As unexpected bilateral ureterotumoral fistulas were detected on renal scintigraphy, removal of the tumor could result in bilateral ureteral dysfunction. Therefore, the treatment plan was changed from surgical resection to conservative management with medication. The patient has been receiving regular clinical follow-up at our medical center.
DISCUSSION
Renal scintigraphy is a very sensitive and non-invasive modality for evaluating renal function and detecting urinary leakage (10). Our patient was clinically suspected to have an ureterotumoral fistula due to the desmoid tumor; however, contrast-en- The optimal treatment for desmoid tumors is controversial and difficult to determine. Clinical follow-up with close observation is recommended for stable asymptomatic patients with a desmoid tumor (1). However, surgical removal is considered to be the first-line treatment for symptomatic patients, and com-plete resection of the desmoid tumor with negative microscopic resection margins is the standard goal (1). However, many clinicians are reluctant to perform a surgical resection because of the high recurrence rate. Moreover, the surgical trauma could cause a recurrence by itself (7) (8) (9) . Complete surgical resection of an in- Fig. 2 . Excretory phase of Tc-99m DTPA renal scintigraphy. Normal radiotracer uptake into the renal cortex and pelvis is seen with radiotracer uptake in the percutaneous nephrostomy tube in the first row. However, the radiotracer is persistently retained and is detected in bilateral renal pelvis and proximal ureters with a cut-off of radioactivity at bilateral mid-ureters (arrows). Only faint radiotracer activity is seen in bilateral distal ureters and increased radiotracer activity is seen in the percutaneous drainage (PCD) tube (arrowhead). The radiotracer did not accumulate in the cystic mass lesion because of the PCD tube. DTPA = diethylenetriamine pentaacetic acid However, because Tc-99m DTPA renal scintigraphy demonstrated bilateral ureterotumoral fistulas, conservative management was selected to avoid complications that may occur after surgical resection.
We report a case of a patient with an intra-abdominal desmoid tumor who showed unexpected bilateral ureterotumoral fistulas on Tc-99m DTPA renal scintigraphy. Tc-99m DTPA renal scintigraphy was helpful to confirm the diagnosis of an ureterotumoral fistula and to decide the treatment plan. 
